Eyal C. Attar - SVP, Chief Medical Officer, Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Medical Officer, Director
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eyal C. Attar since 7/7/2023

Holdings reported by Eyal C. Attar for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 57,233 $211 K $3.68 Jun 3, 2022 Direct
Common Stock 159 $585 $3.68 Jun 3, 2022 By adult child
Stock Option (right to Buy) 185,900 Mar 10, 2022 Direct Common Stock

Transactions reported by Eyal C. Attar for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership